Focusing on CNVs (Figure 5B), ccRCC exhibited amplifications of analyzed genes only in rare cases, whereas deep deletions were much more frequent for PPARG and FANCD2. No similarities were observed when comparing MTUT and endometrial cancers, showing only an increased amplified status for DDR2. In turn, CNV data revealed parallels between bladder cancers and MTUT for most of analyzed genes, such as FGFR1, according to both frequency and type of CNV, i.e., amplifications were mainly present, whereas deep deletions occurred rarely. The gene discussed is FGFR1; the disease is urinary bladder carcinoma.